In silico evaluation of a beta-lactam dosing guideline among adults with serious infections.

Williams, Paul; Cotta, Menino Osbert; Abdul-Aziz, Mohd H; Wilks, Kathryn; Farkas, Andras; Roberts, Jason A

Williams, Paul; Cotta, Menino Osbert; Abdul-Aziz, Mohd H; Wilks, Kathryn; Farkas, Andras; Roberts, Jason A.

Afiliação

Williams P; University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland, Brisbane, Queensland, Australia.
Cotta MO; Pharmacy Department, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.
Abdul-Aziz MH; University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland, Brisbane, Queensland, Australia.
Wilks K; University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland, Brisbane, Queensland, Australia.
Farkas A; Infectious Diseases Department, Sunshine Coast University Hospital, Birtinya, Queensland, Australia.
Roberts JA; School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.

Pharmacotherapy ; 43(11): 1121-1130, 2023 Nov.

Article em En | MEDLINE | ID: mdl-36567467

Assuntos

Antibacterianos; Lactamas; Adulto; Humanos; Meropeném; Cefepima; Ceftazidima; Estado Terminal/terapia; Testes de Sensibilidade Microbiana

Palavras-chave

beta-lactam; critically ill; guideline; nomogram

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lactamas / Antibacterianos Tipo de estudo: Evaluation_studies / Guideline Limite: Adult / Humans Idioma: En Revista: Pharmacotherapy Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google